Skip to main content

The Role of Protein N-Glycosylation in Bone and Energy Homeostasis


Osteoporotic bone loss due to aging or disease is a major health issue that affects hundreds of millions of people worldwide and costs tens of billions of euros each year. Since current osteoporosis medication only reduces fracture risk by 25-50%, there is an urgent need to define new pathways that control bone remodelling and strength in order to identify new therapeutic targets. Via the ‘Mouse Genetics Project’ consortium, we identified a mutation in one of the enzymes involved in the N-linked protein glycosylation pathway that leads to profound osteoporosis and obesity in mice; this observation accorded with the outcome of comparable human pathologies (congenital disorders of glycosylation). Though bone contains a large amount of glycoproteins, the importance of protein N-glycosylation to skeletal homeostasis remains to be characterised. This project aims (1) to identify the role of protein N-glycosylation in bone homeostasis, (2) to assess mechanistically how bone cell functioning is regulated by this process, and (3) to characterise the metabolic abnormalities associated with defects in N-glycosylation and to address its linkage to bone. We hypothesise that defective N-glycosylation impairs bone formation by osteoblasts, leading to the observed osteoporosis, and, likely, reduced bone-derived osteocalcin levels, which will in turn result in hampered insulin release and insulin resistance, with the observed obesity as a consequence. By combining the applicant’s and host’s skills in mouse genetics, skeletal phenotyping and high-throughput techniques, with the expertise in energy homeostasis, mouse embryonic stem cell technologies and (glyco)proteomics at the Wellcome Trust Sanger Institute, we are confident to gain insight in a process that most possibly regulates osteoblast functioning and bone matrix production; this knowledge will contribute to the development of novel, urgently warranted anabolic medication to treat osteoporosis.

Call for proposal

See other projects for this call


The Gibbs Building, Euston Road 215
NW1 2BE London
United Kingdom

See on map

Activity type
Research Organisations
Administrative Contact
Martin Dougherty (Dr.)
EU contribution
€ 221 606,40